Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Y2 LCRS Endocrinology > diabetes > Flashcards

diabetes Flashcards

type 2 Diabetes Mellitus: define type 2 diabetes mellitus, recall the epidemiology, explain the aetiology, pathophysiology, clinical presentations and explain the physiological basis of treatment

1
Q

define DM

A

state of chronic hyperglycaemia sufficient to cause long-term damage to specific tissues (notably retina, kidney, nerves and arteries)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T2DM: ketosis

A

not ketosis prone, but occasionally occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what 3 modifiable things does T2DM often involve

A

weight, lipids, BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

normal, impaired fasting glucose and diabetes levels when fasting

A

normal: <6mmol/l; impaired glucose fasting: 6-7mmol/l; diabetes: >7mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

normal, impaired glucose tolerance and diabetes levels when 2 hours after fasting glucose tolerance test

A

normal: <7.8mmol/l; impaired glucose tolerance: 7.8-11.1mmol/l; diabetes: >11.1mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

random diabetes level

A

> 11.1mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is there a risk of at impaired fasting glucose levels (6-7mmol/l)

A

developing macrovascular disease (atheroma in cerebral circulation and heart etc.), after microvascular disease (retinopathy etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

epidemiology of T2DM

A

most prevalent DM and increasing, associated with increased aged (but now in children due to obesity - genetic condition accelerated by certain lifestyles), greatest in ethnic groups that move from rural to urban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inheritance of T2DM

A

autosomal dominnat condition, but unknown gene location

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is important for T2DM development

A

genes, intrauterine environment, adult environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mechanism of T2DM pathophysiology

A

insulin resistance (less effective) and lack of insulin due to insulin secretion defects (not absolute, as enough insulin to switch off ketone production, but not enough to switch off hepatic glucose output)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why are fatty acids important in pathogenesis and complications of T2DM

A

some can damage B-cells, and are important in insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is MODY and how is it useful in T2DM pathophysiology

A

maturity onset diabetes of the young, which is relatively uncommon but gives useful metabolic insights into T2DM as has known genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hereditary forms and inheritance of MODY

A

1-8 ineritance forms, and is autosomal dominant so positive family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pathophysiology of MODY

A

ineffective B-cell insulin production and glucose sensation, latter caused by mutation of transcription factor genes and glucokinase gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

presentation of weight with MODY

A

no obesity, unlike most T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do genes operate through insulin resistance

A

operate through local factors from adipocytokines, wearing down susceptible B-cells by producing more insulin throughout whole life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

effect on intra-uterine growth restriction (IUGR) on foetus and genes

A

lack of calories in utero can modulate gene expression throughout life (light babies at 1 year more likely to have diabetes or impaired glucose tolerance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what progresses insulin resistance in adulthood

A

obesity and certain fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

impact of metabolic dyslipidia in insulin resistance

A

causes atheroma progression and macrovascular disease (build up of fat in coronary and cerebral circulation for years before high sugar detected); also caused by mitogenic induction and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how is B-cell failure brought about following insulin resistance and outcome on metabolic defects and microvasculature

A

genetic predisposition so can’t make enough insulin, causing metabolic defect and dyslipidaemia to become worse, as well as hyperglycaemia causing microvascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

requirement of B-cell failure following insulin resistance

A

B-cell failure can go on to become absolute, so whilst initial treatment of diet, may eventually need insulin (haven’t changed diagnosis -> insulin deficiency more absolute)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

insulin resistance and postential insulin secretion graph: description of both as age increases in normal and T2DM individuals

A

as get older, insulin resistance (intra-uterine environment) and secretion (genes) increases (unsure in childhood; increases due to microbiota and adipocytes); in those with T2DM, insulin secretion decreases (pancreas makes more immature insulin which doesn’t work properly), so at some point, insulin resistance will be in excess of insulin secretion (even with exercise, diet and medication), so won’t be able to make enough to overcome resistance (absolute insulin deficiency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

describe heterogenous presentation of T2DM

A

variable as BP, cholesterol, glucose etc. may all be more significant in individuals; some more about resistance than secretion deficit and vice versa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
effects of dyslipidaemia in T2DM on vasculature
more cholesterol carried as LDL, damaging arteries, which if found too late presents with heart attack, blindness etc. (acute and chronic)
26
normal pathway of triglyceride breakdown products and metabolism; normal pathway of glycogen in liver; effects on heaptic glucose output
glycerol and NEFA taken to liver by omental circulation; NEFA can’t be used to make glucose (makes VLDL, which then makes triglycerides in adipocytes), but glycerol can be in liver (gluconeogenesis), as can glycogen (glycogenolysis) -> increased hepatic glucose output
27
effect of insulin resistance on glucose uptake and storage and hepatic glucose output, and lipolysis
less glucose uptaken into muscles and liver, so less stored as glycogen, with hepatic glucose output continuing unabated; excess lipolysis increases atherogenic lipid profile
28
normal, developing diabetes and T2DM response to glucose tolerance test
glucose clamped at high levels; in normal individuals, there is a large release of insulin (1st phase), before more is made and released (2nd phase); in developing diabetes, insulin secretion fails, so less able to make 1st phase insulin and more over next 2 hours; there is chronically insufficient insulin in diabetes
29
what is a major endocrine organ involved in T2DM, and how is it predictive of diabetes
adipocytes as make whole range of hormones; all hormones are important in diabetes mechanism (not cause) as a means by which changed metabolism comes about; adiponectin deficiency is associated with decreased insulin resistance
30
type of obesity in T2DM
central adiposity more important than omental adiposity as more metabolically active and endocrine important, as drain directly to liver
31
relationship and effect of obesity and gut microbiota
microbiota can change in obesity and enter liver, altering metabolism including inflammation and host signalling
32
weight gain as a side effect of diabetes treatment, and significance of metformin
metformin is only drug that doesn’t cause weight gain so first line treatment for T2DM-associated weight gain; all others including insulin cause weight gain (less urination etc.)
33
presentation of T2DM
osmotic symptoms, infections (high sugar), obesity, acute complications (hyperosmolar coma), chronic complications (ischaemic heart disease, retinopathy etc,)
34
4 categories of complications of T2DM and its treatment
microvascular, macrovascular, metabolic, treatment (hypoglycaemia)
35
3 microvascular complications of T2DM
retinopathy, nephropathy, neuropathy
36
4 macrovascular complications of T2DM
ischaemic heart disease, cerebrovascular, renal artery stenosis, peripheral vascular disease
37
2 metabolic complications of T2DM
lactic acidosis (less common than ketoacidosis in T1DM), hyperosmolar
38
4 basis of management of T2DM
education, diet, pharmacological treatment, complication screening
39
3 reasons to treat those with T2DM
reduce symptoms, reduce chance of acute metabolic complications (unlikely in T2DM), reduce chance of long term complications
40
7 things to eat and why in controlling T2DM
control total calories/increase exercise (weight), reduce refined carbohydrate (less sugar), increase complex carbohydrate, reduce fat as proportion of calories (less insulin resistance), increase unsaturated fat as proportion of fat (ischaemic heart disease), increase soluble fibre (longer to absorb carbohydrates), address salt (BP risk)
41
4 things to monitor in T2DM
weight, glycaemia, blood pressure, dyslipidaemia
42
drug used to promote weight loss and how it works
orlistat, as GI lipase inhibitor
43
surgical intervention to increase weight loss
gastric bypass, improving diabetes control as hormones made by gut modulate energy intake (food contact with duodenum important in satiety control)
44
when is metoformin administered and what does it do
administered in overweight patients with T2DM where diet alone has not succeded; reduces insulin resistance and hepatic glucose output, and increases peripheral glucose disposal
45
side effects of metformin
GI, and not used if severe liver or cardiac failure, or mild renal failure
46
what is fiver to reduce hepatic glucose output if B-cells are destroyed in T2DM
insulin
47
what do sulfonylureas and meglitinides do in treatment of T2DM, and how; side effect and therefore patients treated
stimulate B-cells to make and secrete more insulin when glucose response in B-cells not working but other machinery is, by shutting ATP-sensitive K+ channel, therefore causing Ca2+ channels to open and insulin to be released; does cause weight gain (only effective in lean with not enough insulin)
48
what does acarbose (a-glucodisade inhibitor) do in treatment of T2DM; side effect
slow down glucose absorption in gut and prolongs absorption of oligosacchardies, allowing insulin secretion to cope following 1st phase insulin; side effect flatus due to small bowel microbiota
49
what do thiazolidinediones (peroxisome proliferator-activated receptor agonists e.g. pioglitazone) do in treatment of T2DM; side effects
distributes weight from dangerous central to peripheral as peripheral insulin sensitiser; also improves lipids and sugar; side effects of older types hepatitis, heart failure
50
what do GLP-1/DPP4 inhibitors do in treatment of T2DM
benefit endogenous B-cells, with anti-glucagon effect
51
describe the incretin effect
oral glucose stimulates greater insulin production than IV glucose due to incretins (gut peptides)
52
what is glucagon like peptide-1 (GLP-1) secreted in response to, what is it a product of and its source, and what does it do
secreted in response to nutrients in gut; transcription product of proglucagon gene, mostly from L cells; stimulates insulin, suppresses glucagon
53
what does GLP-1 do and what is it effective in treating/promoting
increases satiety, restores B-cell glucose sensitivity and is effective for sugar and weight loss
54
GLP-1 degradation: time, enzyme and therapeutic option
short half life (rapid degradation) by dipeptidyl peptidase-4 (inhibited by DPPG-4 inhibitor)
55
2 examples of GLP-1 agonists
exenatide, liraglutide
56
administration of GLP-1 agonists
injection
57
what do long acting GLP-1 agonists do
decrease [glucagon] and [glucose], causing weight loss
58
other name for DPPG-4 inhibitors
gliptins
59
what do DPPG-4 inhibitors do
increase half life of exogenous GLP-1, increase [GLP-1], decrease [glucagon] and [glucose], but neutral effect on weight loss
60
what do SGLT2 inhibitors do | in treatment of T2DM
act on proximal tubules of neprhon, so increase glycosuria to remove glucose
61
example of SGLT2 inhibitor
empaglifozin
62
mechanism of empaglifozin action
inhibits Na-Glu transporter, increasing glycosuria, lowering HbA1c and reducing heart failure risk (Na+ transport in heart)
63
2 other aspects of control of T2DM
blood pressure, diabetic dyslipidaemia
64
what is gestational diabetes
temporary diabetes when pregnant
65
screening for diabetes: 3 problems of diabetes
mortality, morbidity, cost
66
screening for diabetes: difficulties in screening
specific unclear (which test, how often, who etc.)
67
screening for diabetes: difficulties in making a diagnosis
which glucose level is taken (fasted or stimulated), what determines high risk etc.
68
why is DM worth screening for
T2DM onset is preventable, with lifestyle intervention the most effective option at preventing progression vs metformin etc.
69
T1DM vs T2DM: prevalence
T1DM much less than T2DM
70
T1DM vs T2DM: typical age
T1DM: child, adolescent; T2DM: middle-age +
71
T1DM vs T2DM: onset
T1DM: acute; T2DM: gradual
72
T1DM vs T2DM: habitus
T1DM: lean; T2DM: often obese
73
T1DM vs T2DM: family history
T1DM: uncommon; T2DM: common
74
T1DM vs T2DM: geography
T1DM: europids; T2DM: less europids
75
T1DM vs T2DM: weight loss
T1DM: usual; T2DM: uncommon
76
T1DM vs T2DM: ketosis prone
T1DM: yes; T2DM: no
77
T1DM vs T2DM: serum insulin
T1DM: low/absent; T2DM: variable
78
T1DM vs T2DM: HLA association
T1DM: DR3, DR4; T2DM: none
79
T1DM vs T2DM: islet B cells
T1DM: destroyed; T2DM: function
80
T1DM vs T2DM: islet cells autoantibodies
T1DM: present; T2DM: absent

Y2 LCRS Endocrinology (37 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions